Bond.az White LogoBond.az Black Logo

Alico Beats Q2 2026 EPS Forecast by 23%

Alico (ALCO) reports Q2 fiscal 2026 EPS of $1.49, beating estimates by 23%. The company pivots from citrus to land monetization, boosting profitability.

Julianne Alice
ByJulianne Alice- Senior Editor
|
0

Alico, Inc. (ALCO) reported strong financial results for the second quarter of fiscal 2026, with earnings per share (EPS) of $1.49, significantly surpassing the forecasted $1.21 by 23%. The beat reflects the company's successful strategic shift from citrus operations to land monetization.

Despite a 71% year-over-year decline in revenue to $5.2 million, the company's stock rose 1.2% in after-hours trading to close at $41.17, signaling investor confidence in the new strategy.

Management emphasized the benefits of exiting the citrus business and focusing on land development. "Our shift to a diversified land utilization model has significantly improved our financial performance," said the CEO.

The company expects year-end cash of approximately $40 million and net debt of $45 million. Alico's land portfolio of 46,000 acres is valued between $650 million and $750 million.

More News
Today / 13:51
|
926

MiNK Therapeutics Q1 2026: Strategic Progress

MiNK Therapeutics Q1 2026 earnings: strategic progress, financial results, and updates on AGENT-797 platform.

0
Today / 13:24
|
926

Kepler Weber Q1 2026: Mixed Results

Kepler Weber reported mixed Q1 2026 results with international growth offsetting domestic declines. EBITDA margin stable at 11%.

0
Today / 13:22
|
694

Acumen Pharmaceuticals Beats Q1 2026 EPS Forecast

Acumen Pharmaceuticals beats Q1 2026 EPS forecast with -$0.33, but stock falls on cautious sentiment. Details on ALTITUDE-ad trial and EBD program.

0
Today / 13:20
|
536

PAVmed Q1 2026: Restructuring Gains Highlighted

PAVmed Inc. reported Q1 2026 results with restructuring gains and product development progress. Stock up 3.1%.

0
Today / 13:13
|
921

Lifeward strategic moves amid revenue decline

Lifeward reports Q1 2026 revenue decline but gains investor confidence through strategic acquisitions. Read more on Bond.az.

0
Today / 13:10
|
236

Friedrich Vorwerk Q1 2026: Strong Results, Stock Drops

Friedrich Vorwerk Q1 2026 results: strong financials, stock drop. Growth expected in hydrogen and energy transition.

0
Today / 12:01
|
485

Exodus Q1 2026 earnings: mixed results revealed

Exodus Movement Q1 2026 results mixed: EPS beat but revenue miss. Stock falls 14.79% after hours.

0
Today / 09:34
|
540

Galapagos NV Revenue Drops 91% in Q1 2026

Galapagos NV reports 91% revenue drop in Q1 2026 but achieves net profit. Details on transformation and gamgertamig potential.

0
Today / 09:33
|
271

KT Corp Q1 2026 Earnings Miss Expectations

KT Corporation Q1 2026 earnings miss estimates. EPS $0.4948 vs $0.5325 forecast. Stock down 3.43%. Company shifts to AI-driven AX platform strategy.

0
Today / 09:27
|
700

Multiconsult Q1 2026 misses EPS expectations

Multiconsult Q1 2026 results: EPS misses expectations, revenue slightly below forecasts, stock price dips modestly.

0
Today / 09:04
|
728

Village Farms Q1 2026 Shows Strong Revenue Growth

Village Farms Q1 2026 results: EPS met, revenue beat. Cannabis sales up 27%. Stock rises 3.89% in pre-market. Strong financial health per Bond.az.

0
Today / 09:03
|
946

Eisai Q4 2025: Record Revenue, Profit Declines

Eisai Q4 2025 financial results: record revenue but profit declines. Analysis of LEQEMBI, DAYVIGO, and LENVIMA performance.

0
...